Picture of Cosmo Bio logo

3386 — Cosmo Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareConservativeMicro CapContrarian

Table: Cosmo Bio -2018 group results

Feb 14 (Reuters)- 
          Cosmo Bio Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Dec 31, 2018    Dec 31, 2017   Dec 31, 2019     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           7.26            7.07           7.40          3.75    
               (+2.7 pct)      (-4.8 pct)     (+1.9 pct)    (-1.3 pct) 
  Operating      328 mln         193 mln        200 mln       90 mln   
               (+70.1 pct)     (-62.5 pct)    (-39.1 pct)  (-61.4 pct) 
  Recurring      403 mln         397 mln        250 mln      125 mln   
               (+1.6 pct)      (-17.8 pct)    (-38.1 pct)  (-56.2 pct) 
  Net
  Net            260 mln         237 mln        140 mln       65 mln   
               (+9.4 pct)      (-6.5 pct)     (-46.2 pct)  (-64.6 pct) 
  EPS           43.93 yen       40.15 yen      23.62 yen    10.96 yen  
  Ann Div       14.00 yen       14.00 yen      14.00 yen               
  -Q2 Div       6.00 yen        6.00 yen       6.00 yen                
  -Q4 Div       8.00 yen        8.00 yen       8.00 yen                
  
  NOTE - Cosmo Bio Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3386.T

Recent news on Cosmo Bio

See all news